Kanion Pharmaceutical (600557.SH) issued an announcement that its wholly-owned subsidiary, Jiangsu Kanion Pharmaceutical Technology Development Co., Ltd....
Finance and Economics APP News: Kanion Pharmaceutical (600557.SH) announced that its wholly-owned subsidiary Jiangsu Kanion Pharmaceutical Technology Development Co., Ltd., (referred to as "Kanion Pharmaceutical Technology") and Jiangsu Xinjiyu Construction Engineering Co., Ltd., (referred to as "Jiangsu Xinjiyu", formerly known as Nantong Mingyuan Construction Engineering Co., Ltd.) plan to sign an agreement on the exterior decoration and laboratory engineering framework of the first building of Kanion Pharmaceutical Technology Park project (National Key Laboratory for Traditional Chinese Medicine Process Control and Intelligent Manufacturing Technology project), which stipulates that Jiangsu Xinjiyu will provide Kanion Pharmaceutical Technology with construction, exterior decoration, and laboratory engineering project construction services, with an estimated total amount of 16.3 billion yuan.